Your browser doesn't support javascript.
loading
CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy.
Tse, Benita C Y; Bergamin, Sarah; Steffen, Pascal; Hruby, George; Pavlakis, Nick; Clarke, Stephen J; Evans, Justin; Engel, Alexander; Kneebone, Andrew; Molloy, Mark P.
Affiliation
  • Tse BCY; Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Bergamin S; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, Australia.
  • Steffen P; Bowel Cancer and Biomarker Laboratory, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Hruby G; Department of Radiation Oncology, Royal North Shore Hospital, Sydney, Australia.
  • Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.
  • Clarke SJ; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.
  • Evans J; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.
  • Engel A; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.
  • Kneebone A; Colorectal Surgical Unit, Royal North Shore Hospital, Sydney, Australia.
  • Molloy MP; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.
Oncoimmunology ; 12(1): 2238506, 2023.
Article in En | MEDLINE | ID: mdl-37485033

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / T-Lymphocytes / CD11c Antigen / Interferon Regulatory Factors Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncoimmunology Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / T-Lymphocytes / CD11c Antigen / Interferon Regulatory Factors Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncoimmunology Year: 2023 Document type: Article